Jeffrey Cooper received his O.D from Pennsylvania College of Optometry in 1971 and an M.S. in Physiological Optics from State University of New York in 1978. He completed a residency in Binocular Vision and Visual Perception in 1971 and subsequently was appointed the co-chairman of the vision therapy department. He taught at the SUNY College of Optometry from 1971 to 2015, where he obtained the rank of Clinical Professor. He taught in both the professional program and the residency program strabismus and amblyopia diagnosis and treatment; in addition, he taught in the primary care department, vision therapy department and ocular disease departments. He retired as Professor Emeritus. He has authored over 60 peer reviewed papers dealing with anomalies of binocular vision, stereopsis, and glaucoma. He served as the principal investigator of two NIH/NEI clinical trials. He was one of the first optometrists to incorporate atropine into his practice to slow the progression of myopia. Currently, he has two offices consisting of 4 optometrists and 3 ophthalmologists in Manhattan and Brooklyn. He is the inventor of both Computer Orthoptics and the HTS programs which were used in the CITT clinical trials. He is on the advisory boards of VTI, Alcon, Treehouse, Computer Orthoptics, and Magic Leap.
Sessions
Myopia: The New Hot Disease Affecting Billions – How to Treat It (Q&A to follow via Zoom link)